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Abstract
Human mesenchymal stem cells (hMSC) have the ability to differentiate into osteoblasts, adipocytes and chondrocytes. We
have previously shown that hMSC were endowed with a basal level of Hedgehog signaling that decreased after
differentiation of these cells. Since hMSC differentiation is associated with growth-arrest we investigated the function of Hh
signaling on cell proliferation. Here, we show that inhibition of Hh signaling, using the classical inhibitor cyclopamine, or a
siRNA directed against Gli-2, leads to a decrease in hMSC proliferation. This phenomenon is not linked to apoptosis but to a
block of the cells in the G0/G1 phases of the cell cycle. At the molecular level, it is associated with an increase in the active
form of pRB, and a decrease in cyclin A expression and MAP kinase phosphorylation. Inhibition of Hh signaling is also
associated with a decrease in the ability of the cells to form clones. By contrast, inhibition of Hh signaling during hMSC
proliferation does not affect their ability to differentiate. This study demonstrates that hMSC are endowed with a basal
Hedgehog signaling activity that is necessary for efficient proliferation and clonogenicity of hMSC. This observation unravels
an unexpected new function for Hedgehog signaling in the regulation of human mesenchymal stem cells and highlights the
critical function of this morphogen in hMSC biology.
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Introduction
Mesenchymal stem cells (MSC) reside in a variety of tissues and
can differentiate into adipocytes, osteoblasts, and chondrocytes.
The number of MSC present in the organism is dependent upon
their rate of differentiation and self-renewal properties, i.e. their
ability to proliferate without losing their differentiation properties.
Both processes are highly regulated and their deregulation alters
the homeostasis of various organs and can give rise to pathologies
such as obesity and osteoporosis [1,2].
The molecular mechanisms presiding upon hMSC self-renewal
are not completely unraveled. hMSC self-renewal depends upon
FGF [3], Activin A [4] and Wnt [5], but other factors are likely to
be involved. Hedgehog, originally discovered in Drosophila, is an
important morphogen that controls a variety of mammalian
developmental phenomena such as induction of the ventral cell
fates in the central nervous system and patterning of the anterior-
posterior axis of the developing limb [6,7,8,9]. Hh has also
homeostatic functions in post embryonic tissues controlling cell
growth, axon guidance and cell differentiation. Shh controls self-
renewal of neural stem cells [10,11,12], hair follicle stem cells [13]
and mammary stem cells [14]. Moreover, an abnormal activity of
Hh signaling is thought to be responsible for the anarchic self-
renewal properties of several cancer stem cells such as the one
found in gastrointestinal, breast and brain cancers [9,15,16].
We have shown that Hh controls the differentiation
properties of hMSC, through a species-specific effect [17,18].
Moreover, differentiation of hMSC into adipocytes [17] or
osteoblasts [18] is associated with a decrease in Hh signaling.
Since hMSC differentiation is associated with growth-arrest, Hh
signaling appeared as a candidate for controlling proliferation of
these cells. As we previously shown that stimulation of Hh
signaling did not affect the proliferation of hMSC we
investigated the effect of an inhibition of Hh signaling on
hMSC proliferation.
Schematically, Hh signaling is initiated by the binding of Hh
(Sonic Hedgehog, Indian Hedgehog or Desert Hedgehog), to its
receptor, Patched (Ptc). Upon binding, Ptc relieves its suppression
on Smo [15]. Smo is then localized into the primary cilium of the
cell, an organelle playing a critical role in Hh signaling [19,20].
There, Smo activates an intracellular cascade that results in the
stabilization of Gli2. This transcription factor translocates into the
nucleus and induces the transcription of Hh target genes, such as
Gli1, a reliable marker of Hh signaling [7,9,21]. Gli2 is a critical
component of Hh signaling and its inactivation leads to an
inhibition of Hh signaling.
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16798Here, we show for the first time that inhibition of Hh signaling
inhibits the proliferative and clonogenic properties of hMSC,
without modifying their ability to differentiate.
Results
Hh signaling is modulated during cell differentiation
Previous studies indicated that differentiation of hMSC into
adipocytes and osteoblasts is associated with a decrease in Hh
signaling [17,18]. Since hMSC differentiation is associated with
cell growth-arrest we investigated the function of Hh signaling in
hMSC proliferation. To this purpose, we used hMADS cells which
are human adipose-derived MSC. These cells are multipotent,
display a normal karyotype and are not transformed [22].
We have previously shown that activation of Hh signaling by
purmorphamine did not modify proliferation of hMSC [17].
However, Hh signaling was found to be active in undifferentiated
cells and decreased after cell differentiation. This is illustrated in
Figure 1 where hMADS were differentiated into adipocytes,
osteoblasts or kept in an undifferentiated state. Gli-1 mRNA
expression, which has been established to reflect Hh signaling
activity [7,9,21], was monitored by real time RT-PCR. As
observed, hMADS differentiation into osteoblasts or adipocytes
is associated with a decrease in Hh signaling.
In order to investigate the effect of the inhibition of Hh signaling
on hMSC self-renewal we used the classical inhibitor cyclopamine
[23]. This molecule, which binds directly to smoothened, is a
classical specific inhibitor of the Hh pathway that has been
extensively used in in vivo and in vitro experiments. As observed
(Figure 1B) cyclopamine induces a 50% decrease in Gli-1
expression at 5 mM. It was the maximal concentration we used
in our subsequent experiments since its effect on Hh signaling was
similar to the one observed after cell differentiation, and to avoid
possible specificity issues [24].
Inhibition of Hh signaling decreases hMADS cell
proliferation
We tested the effect of an inhibition of Hedgehog signaling on
cell proliferation. First, cells were treated or not with cyclopamine
(5 mM) and counted every 3 days (Figure 2A). As observed,
cyclopamine induced a 25% decrease in cell proliferation after 12
days. A dose-response experiment was performed (Figure 2B).
1 mM cyclopamine induced a modest decrease in cell proliferation.
This inhibition reaches 37% at 5 mM. Similar results were
obtained with another hMADS cell line (data not shown).
To make sure that the inhibition of proliferation observed with
cyclopamine was specific of a decrease of Hh signaling, we used a
siRNA directed against Gli-2. Indeed, Gli-2 is a critical
transcription factor in the Hh signaling pathway and its activation
is necessary for Gli-1 expression [9,15]. Cells were transfected with
a non relevant (NR) siRNA or a siRNA directed against Gli-2
(Figure 2C), RNAs were extracted and Gli-2 and Gli-1 mRNAs
expression monitored using quantitative RT-PCR. As observed,
Gli-2 siRNA induces a 60% decrease in Gli-2 expression. As
expected, this was accompanied by a 90% inhibition of Gli-1
expression.
We then tested the effect of Gli-2 silencing on hMADS
proliferation. hMADS were transfected or not with a non-relevant
siRNA or a siRNA directed against Gli-2. After 5 days cells were
counted (Figure 2D). Inhibition of Gli-2 expression leads to a 27%
decrease in cell proliferation. Since cyclopamine and siRNA
against Gli-2 provided similar results all subsequent experiments
were performed using cyclopamine.
We tested the effect of cyclopamine on the proliferation of
hMSC primary cultures obtained from bone marrow. Cells were
treated with cyclopamine and counted after 5 and 10 days
(Figure 2E). As observed, cyclopamine decreases bone marrow
hMSC cell proliferation, indicating that the effect observed was
not restricted to hMADS cells.
Inhibition of Hh signaling does not affect cell viability
We investigated the mechanism by which Hh inhibition
decreases cell proliferation. Hh inhibition has been shown to
induce apoptosis in some cell models such as glioblastoma,
pancreatic cancer cells and during early embryonic stem cell
neurogenesis [25,26,27]. We tested the effect of cyclopamine on
hMSC viability by performing an annexinV-FITC/propidium
iodide (PI) assay. AnnexinV–FITC detects phosphatidylserine at
the surface of the cell membrane, an early step of the apoptotic
program. Cells positive for both annexin V and PI are considered
to be apoptotic while cells positive only for PI are necrotic.
hMADS cells were incubated with cyclopamine for 24 hours or
5 days or staurosporine for 24 hours as a positive control for cell
death. Staurosporine increased the percentage of positive cells for
Figure 1. Hedgehog signaling is downregulated during differentiation of hMADS cells. hMADS cells were kept undifferentiated or
differentiated into adipocytes or osteoblasts (A), or treated with increasing concentrations of cyclopamine for 7 days (B). Gli-1 expression was
evaluated by real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR). Results are representative of three independent
experiments.
doi:10.1371/journal.pone.0016798.g001
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cyclopamine (5 mM) did not affect significantly the amount of
annexinV-positive cells (Figures 3A and 3B). These results indicate
that apoptosis is not implicated in the inhibition of proliferation
induced by cyclopamine.
Inhibition of Hh signaling affects cell cycle
Since inhibition of Hh signaling does not affect cell viability we
investigated whether it affects the cell cycle. Cell cycle distribution
was evaluated by cyclin A and PI double labelling and analyzed by
flow cytometry (Figure 4). Cyclin A is expressed at the end of the
G1 phase/beginning of the S phase through the end of the G2
phase, while PI reflects DNA content of the cells. Thus, cells with
low PI and low cyclin A are in G0/G1 phase (gated in R2), cells
with high cyclin A and high PI are in S/G2 (R3) while cells with
high PI and low cyclin A (R4) are in M phase.
First, cells were synchronized. Incubation of hMADS in
DMEM without serum for 48 hours results in 91% of cells
Figure 2. Inhibition of Hh signaling decreases hMSC proliferation. (A): hMADS cells were grown in presence of FGF-2 (2.5 ng/ml) and treated
every other day with (square) or without (circle) cyclopamine (5 mM) for 12 days, then counted at the indicated time. (B): Dose response of
cyclopamine on cell proliferation. Cells were grown for 6 days with increasing doses of cyclopamine and counted. (C): Cells were transfected with a
non relevant (NR) siRNA or a siRNA directed against Gli 2. After 72 hours mRNA were extracted and Gli2 and Gli1 expressions were evaluated by
quantitative RT-PCR. (D): Number of hMADS cells 3 days after transfection with a non relevant siRNA or a Gli2 siRNA. The data presented are means 6
SE of three independent experiments performed in triplicate. (E): Proliferation curve of hMSC from bone marrow. Cells were treated with cyclopamine
(5 mM) and counted after 5 and 10 days. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0016798.g002
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and quantification provided in 4E). hMADS cells were then
incubated in growth medium (10% FCS and FGF-2) for 24 h in
presence or in absence of cyclopamine (5 mM) (Figures 4C, 4D and
4E). As expected, growth medium led to a significant reduction of
cells in G0/G1 (65.1% compared to 91.1%) and an increase of
Figure 3. Inhibition of Hh signaling does not affect cell viability. (A): Flow cytometry analysis of hMADS cells treated with cyclopamine for
24H or 5 days and labelled with annexin V and propidium iodide (PI). The percentage of cells positively labelled with annexin V (apoptotic cells) is
indicated for each condition. Staurosporine was used as a positive control (0.1 mM for 24H). (B): Percentage of Annexin V-positive cells after a
treatment of 5 days with 5 mM cyclopamine.
doi:10.1371/journal.pone.0016798.g003
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in G0/G1 increased (79.2% compared to 65.1% in absence of
cyclopamine) and cells failed to cycle into the S phase (16.7%
compared to 30.5% in absence of cyclopamine).
Then, we analyzed the expression of several key markers of the
cell cycle. Cells were synchronized as described above, and
proteins or RNA were extracted. Western Blot experiments
indicate that treatment of cells with cyclopamine decreased the
hyperphosphorylated form of pRb (P-pRb) while increasing its
hypophosphorylated form (Figure 5A). The hypophosphorylated
form of the tumor repressor pRB represents its active form that
binds E2F to decrease cell proliferation. Cyclopamine induced a
(50%+/28%, p,0.001, measured as described in Methods)
decrease in Cyclin A expression (Figure 5A). This was associated
with a decrease in the number of Cyclin A positive cells, as
measured by FACS (Figure 5B) and a decrease of Cyclin A mRNA
expression (Figure 5C). Cyclopamine decreased MAPK phos-
phorylation by 27% (+/28%, p,0.01). By contrast, cyclin D1 and
Cyclin E1 expressions were not modified significantly (Figure 5A).
Q-PCR analysis of cyclin A E1 and D1 were consistent with the
results obtained by Western Blot (Figure 5C).
These data indicate that inhibition of Hh signaling delayed the
cells in G0/G1 phase and is associated with an increase in the
active form of pRB, a decrease in cyclin A expression and of MAP
kinase phosphorylation.
Inhibition of Hh signaling decreases hMADS
clonogenicity
Clonogenicity, i.e. the ability to expand at a single cell level is an
important feature of self-renewing stem cells. To test the effect of a
decrease Hh signaling on hMSC clonogenicity, cells were plated at
low density in presence or in absence of cyclopamine. After 3
weeks, cells were fixed and stained with crystal violet in order to
visualize cell colonies (Figure 6A). As observed cyclopamine
induces a 50% decrease in the number of colonies. Moreover, in
presence of cyclopamine the colonies were less dense than the
control colonies, which is consistent with the effect of cyclopamine
on cell proliferation.
We tested the specificity of Hh signaling by silencing Gli-2. Cells
were transfected with or without a control siRNA or a siRNA
against Gli-2. 24 hours later, cells were trypsinised and seeded at
low density. After 3 weeks, cells were stained with crystal violet and
the colonies were counted. As observed, control siRNA did not
affect hMSC clonogenicity but Gli-2 silencing was associated with
a 40% decrease in the number of clones (Figure 6B).
Inhibition of Hh signaling during proliferation of hMSC
does not affect their ability to differentiate
The effect of cyclopamine on hMSC differentiation has already
been reported [17]. Here, we investigate if the inhibition of Hh
signaling during cell proliferation affected their ability to
differentiate in absence of Hh inhibition. To do this, cells were
grown in presence or absence of cyclopamine (5 mM). When cells
reached confluence (usually three days later for the cyclopamine-
treated cells), cyclopamine was removed from the medium and
cells were treated with an adipogenic or an osteogenic medium.
After 10 days, RNA were extracted and the expression of
adipogenic: aP2, PPARc and C/EBP-a or osteoblastic markers;
Alkaline Phosphatase (ALPL), Runx-2 and osteoprotegerin was
evaluated by quantitative PCR. No significant difference was
observed between conditions (Figures 7A and 7B).
We then analyzed if a pre-treatment with cyclopamine could
modify the ability of the cells to differentiate preferentially into
adipocytes or osteoblasts. To do this, after cyclopamine treatment,
cells were treated with a ‘‘dual’’ differentiation medium allowing
the differentiation into adipocytes and osteoblasts. Expression of
differentiation markers was then analyzed. As observed in
Figure 7C pre-treatment with cyclopamine did not favor one type
of differentiation over the other.
Cell-cycle arrest is though to be necessary for cell differentiation
of hMSC. We decided to test whether the accumulation of cells in
G0/G1 phase induced by Hh signaling inhibition could favor cell
differentiation. Cells were plated at low density and synchronized
as described above. Cells were then treated with cyclopamine.
After 24 hours cyclopamine was removed and the subconfluent
cells were incubated in an adipocyte or an osteoblast differenti-
ation medium. After 10 days RNA were extracted and
differentiation was evaluated through the expression of markers.
(Figure 8). When differentiation was induce before the cells had
reached confluence, cells were less differentiated than under
‘‘classical conditions’’ and C/EBP-a was expressed at low level,
that did not allowed quantification. So, instead of C/EBP-a we
analyzed the expression of another adipocyte marker: SREBP1-c.
No significant difference was observed between conditions.
Discussion
MSC are used extensively to unravel molecular processes
leading to cell differentiation. These cells are also currently used in
several cellular therapy clinical trials [28]. Thus, a precise
understanding of the self renewal properties of these cells, i.e.
their ability to proliferate without losing their differentiation
ability, seems of particular importance. Several molecules control
hMSC self-renewal such as FGF-2 [3], Activin A [4] and Wnt [5].
Here, we show that Hh signaling regulates proliferation and
clonogenicity of hMSC. Hh is known to control self renewal of
various stem cell types during embryogenesis [10,11,12,15,29]. It
has also important functions in adult stem cells such as stem cells of
the hair follicle epithelium [13], of the gastrointestinal tract [30],
in the sebaceous lineage [31] or in the particular case of cancer
stem cells [9,15,16]. hMSCs appear as a new adult stem cell type
regulated by Hh. The mechanism appears somehow unusual
since, in contrast to what is observed in other non-cancer stem
cells, hMSC are endowed with a basal level of Hh signaling. This
basal activity appears necessary and sufficient to maintain hMSC
proliferation since proliferation is not further stimulated by Hh
treatment of the cells [17]. What maintains this basal Hh signaling
activity? In hMADS cells, Ihh and Dhh mRNA are detectable by
real time PCR, but at low levels [17,18]. It is unclear whether this
low level of messenger is sufficient to produce enough ligand to
maintain a basal activity of Hh signaling. TGF has been shown to
induce Hh signaling under some circumstances [32,33]. However,
Hh and TGF pathways are thought to interact downstream of
Smo. Since cyclopamine targets Smo it should not affect an
induction of Hh signaling by TGF. Finally, it could be envisioned
Figure 4. Inhibition of Hh signaling affects hMADS cell cycle. Cell cycle distribution was evaluated by a Cyclin A antibody and PI double
labelling and analysed by flow cytometry. (A): cell cycle distribution of proliferating hMADS. (B–D) hMADS cells were synchronised as described in
‘‘Methods’’ and (B) placed in DMEM in absence of serum for 48H or (C) incubated in growth medium (10%FCS and FGF-2 (2.5 ng/ml)) for 24H in
absence or (D) in presence of cyclopamine (5 mM). (E) Distribution of cells in G0/G1 (R2 gate), S/G2 (R3 gate) or M (R4 gate) phases of the cell cycle are
indicated in the table. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0016798.g004
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maintained by an incomplete inhibition of Smoothened by
Patched. Indeed, although the precise mechanism that leads Ptc
to inhibit Smo is not resolved, it is well established that a decrease
in Ptc expression, or activity, is associated with an increase in Hh
signaling. This is observed in Gorlin syndrome which is associated
with Ptc mutations [15]. Such an uncoupling between Ptc and
Smo in hMSC could be envisioned in hMSC.
In several stem cells and cancer cells Hh acts as a survival factor
[25,26,27,34]. Inhibition of Hh signaling in hMSC did not modify
their viability, indicating that the cell cycle was affected. Hh has
been reported to control the proliferation of several cell types
through various molecular mechanisms such as; an increase in
cyclin D expression [15,16], modulation of pRb phosphorylation
through cyclin D and cyclin E in cerebellar granule neuron
precursors [35], the increase in E2F1, CDC2 and CDC45L in
Figure 5. Inhibition of Hh signaling affects key markers of the cell cycle. hMADS cells were synchronised as described in ‘‘Methods’’ and
treated with increasing concentrations of cyclopamine for 24H. (A): Western blot of pRb (the upper band ‘‘P-pRb’’ is the hyperphosphorylated form of
pRb), Cyclins A, E1 and D1, phospho-MAPK and total MAPK. Tubulin antibody was used as a loading control. Western blot are representative of
experiments performed at least 3 times. (B): Flow cytometry analysis of cyclin A-positive cells after treatment with cyclopamine for 24H (5 mM).
(C): Quantitative RT-PCR for Cyclins A, D1 and E1. Data are means 6 SE of triplicates from an experiment representative of three independent
experiments.
doi:10.1371/journal.pone.0016798.g005
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the association of the tumor suppressor p53 with mdm2 in cells
expressing Hh or a constitutively active smoothened [37]. In
hMSC, our experiments indicate that cyclopamine delays the cells
in the G0/G1 phase. This is associated with an increase in the
active form of pRB that can be linked to the associated decrease in
cyclin A. Indeed, cyclin A binds cdk2 that phosphorylates and
inactivates pRb during the late G1 and S phases. Such a decrease
in cyclin A expression by cyclopamine has previously been
documented in ovarian carcinoma [38]. In addition, cyclopamine
decreases the phosphorylation of MAP kinases which are well-
described activators of cell proliferation. Interactions between Hh
and ERK signaling pathway have previously been observed in
cancer cells such as melanoma [34]. Thus, in hMSC basal Hh
activity appears necessary for cyclin A expression, pRb phosphor-
ylation and ERK activity.
Interestingly, although Hh signaling inhibition decreases hMSC
proliferation and clonogenicity it does not affect their differenti-
ation potential. Likewise, the cell-arrest state induced by inhibition
of Hh signaling appears insufficient to favor a differentiation
mechanism. This is somehow different to what has been observed
with FGF-2 [3]. Indeed, hMSC that are deprived of FGF-2 during
proliferation have lower adipogenic potential, even when FGF-2 is
removed during differentiation. Thus, Hh signaling controls the
proliferation rate of hMSC but does not hinder their further ability
to differentiate. By contrast, Hh signaling is known to interfere
with hMSC differentiation [17,18]. Our results suggest that Hh
signaling function as a morphogen that, at basal level, is necessary
for optimal hMSC proliferation and clonogenicity, while it affects
cell differentiation when activated.
Together, this study reveals that endogenous Hh signaling
controls the proliferation and clonogenicity of hMSC. This new
function for Hh signaling, together with previous reports
demonstrating that Hh controls hMSC differentiation, high-
light the cardinal function of this morphogen in hMSC
homeostasis.
Figure 6. Inhibition of Hh signaling inhibits colony formation of hMADS cells. Cells were plated at clonal density and maintained in
medium supplemented with 10% FCS and FGF-2 (2.5 ng/ml) (Ctrl). One day after cell plating, 5 mM cyclopamine was added to the culture medium.
(A): Photographs of colony formation of hMADS cells 3 weeks after treatment. A magnification of one colony is presented for each condition.
(B): Photographs of colony formation of hMADS cells transfected with non relevant (NR) siRNA, Gli2 siRNA or only with hyperfect as a control
(indicated ‘‘none’’ in the figure). Graphs represent the percentage of colony-forming cells in three independent experiments.
doi:10.1371/journal.pone.0016798.g006
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Cell cultures
For the isolation of hMADS-2 and hMADS-3 cells from young
donors, adipose tissues were obtained with the written consent of
the parents as surgical scraps from surgical specimen of various
surgeries, as approved by the Centre Hospitalier Universitaire de
Nice Review Board, as previously described [22,39]. To follow
French bioethics laws, donors remain anonymous and files are
kept at the Centre Hospitalier Universitaire de Nice. Self-renewal
properties and ability of these cells to differentiate into adipocytes
and osteoblasts have been extensively described in [3,39,40].
hMSC isolated from bone marrow were purchased from Cambrex
(Cambrex, Emerainville, France). Cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum (FCS), 2,5 ng/ml human fibroblast growth factor
Figure 7. Inhibition of Hh signaling during hMADS proliferation does not affect differentiation potential. hMADS cells were grown in
presence or in absence of cyclopamine (5 mM) until confluence for 10 days. Then cyclopamine was removed and cells were induced to differentiate
into (A) adipocytes or (B) osteoblasts or (C) both (50% adipogenic and 50% osteogenic media). After 10 days mRNA were extracted and aP2, PPARc,
C/EBP-a, Runx-2, osteoprotegerin and ALPL expressions were evaluated by quantitative RT-PCR.
doi:10.1371/journal.pone.0016798.g007
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ml streptomycin. hFGF-2 was removed when cells reached
confluence.
hMADS cell differentiation
Adipocyte differentiation was performed as described previously
[39]. Confluent cells were cultured in DMEM/Ham’s F12 media
supplemented with transferrin (10 mg/ml), insulin (0.86 mM),
triiodothyronine (0.2 nM), dexamethasone (1 mM), isobutyl-meth-
ylxanthine (100 mM) and rosiglitazone (500 nM). Three days later,
the medium was changed (dexamethasone and isobutylmethyl-
xanthine were omitted). For osteoblasts, confluent cells were
cultured in a-MEM medium containing 1% FCS supplemented
with 200 mM L-ascorbic acid phosphate, 10 mM a-glycerophos-
phate, 100 nM dexamethasone, and 10 ng/ml epidermal growth
factor. For simultaneous adipocyte and osteoblast differentiation,
confluent cells were cultured in the differentiation medium
consisting of 50% adipogenic and 50% osteogenic media.
Cell proliferation assays
Cells were plated onto 6-well plates (4,500 cells per cm
2). When
indicated, cyclopamine was added 24 hours after cell plating in
order to avoid a potential effect of the compounds on cell
attachment. At the appropriate time, adherent cells were
dissociated in 0.25% trypsin/EDTA and counted with a Coulter
counter. For each experiment, three wells per condition were
counted.
Apoptosis assays
Apoptosis was assessed by measuring membrane redistribution
of phosphatidylserine using an annexin V-FITC apoptosis
detection kit (Invitrogen, Cergy Pontoise, France). According to
the furnisher protocol, after cyclopamine treatment, cells were
collected, washed with PBS and resuspended in 500 mL of staining
solution containing FITC-conjugated annexin V antibody and
propidium iodide (PI). After incubation at room temperature for
20 min, cells were analysed by flow cytometry. Basal apoptosis and
necrosis were identically determined on untreated cells. Staur-
osporine was used as a positive control. Analysis was performed on
a Calibure FACS (BD, Le Pont de Claix, France) and at least
10,000 events were acquired per sample.
Cell cycle analysis by FACS
hMADS cells were synchronised before cell cycle assays. Briefly,
cells were plated on 75-mm dishes (4,500 cells/cm
2) and grown in
DMEM 10% FCS and hFGF-2. After 24 hours the serum was
removed for 48 hours to arrest cells in G0/G1. Then, hMADS
cells were incubated in growth medium (10% FCS and hFGF-2)
for 24 h in presence or in absence of cyclopamine (5 mM). Cells
were trypsinized, fixed in cold 70% ethanol and then permeabi-
lized in a PBS/1% triton (v/v) solution for 10 minutes. Cell cycle
distribution was evaluated by cyclin A and PI double labelling.
Cells were incubated with an anti-cyclin A antibody (Novocastra,
Rungis, France) for one hour followed by an incubation with an
Alexa Fluor 488 conjugated-antibody (Invitrogen) for 30 minutes.
Figure 8. Cell-arrest induced by inhibition of Hh signaling does not affect hMSC differentiation. hMADS cells were synchronised as
described in ‘‘Methods’’ and treated with 5 mM cyclopamine. After 24 hours cyclopamine was removed and the subconfluent cells were treated with
an adipocyte or an osteoblast differentiation cocktail. After 10 days mRNA were extracted and aP2, PPARc, SREBP1-c, Runx-2, osteoprotegerin and
ALPL expressions were evaluated by quantitative RT-PCR. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0016798.g008
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(0,1%), RNase A (20 mg/ml) and PI (40 mg/ml). Analysis was
performed on a Calibure FACS (BD Biosciences) and at least
10,000 events were acquired per sample.
Cell transfection
hMADS cells were transfected with a siRNA directed against
Gli2 (seq: GAU-CUG-GAC-AGG-GAU-GAC-UTT) or a non-
relevant siRNA with HiPerfect Transfection Reagent (Qiagen,
Courtaboeuf, France) as recommended by the manufacturer.
Briefly, cells were seeded at high density (30,000 cells/cm
2)i n6o r
12 well plates. After 24 hours cells were transfected with 50 nM
siRNA previously mix with HiPerfect. For proliferation assays,
cells were seeded in 12-well plates and counted 3 days after
transfection. For clonal assays cells were transfected in 6-well
plates, trypsinized 24 hours later and seeded at 10 cells/cm
2 in 75-
mm dishes.
Clonal assays
Cells were plated at a density of 10 cells/cm2 in 75-mm dishes.
When indicated, cyclopamine was added 24 hours after cell
plating. 21 days after plating cells were fixed with 0.25%
glutaraldehyde and stained with 0.1% crystal violet. Colonies
containing at least 40 cells were enumerated under a light
microscope. Medium was changed 3 times a week.
Preparation of Cell Extracts and Western Blot Analysis
Cells were lysed in stop buffer (50 mM Hepes, pH 7.2, 150 mM
NaCl, 10 mM ethylene-diamine-tetra-acetate, 10 mM Na4P2O7,
2 mM Na3VO4, 100 mM NaF, 1% Triton X-100 (v/v) in
presence of Complete TM inhibitor cocktail (Roche Molecular
Biochemicals, Paris, France). Primary antibodies were pRb (BD
Bioscience), cyclins A, E1 and D1 (SantaCruz, CA) pMAPK, total
MAPK (Cell signaling technologies) and tubulin (Sigma). Second-
ary horseradish peroxidase-conjugated antibodies were purchased
from Dako (Trappes, France) or Promega. Western Blots were
revealed using a ChemiDoc XRS System from Bio-Rad. For
quantification, Western Blots from at least three independent
experiments were analysed using ‘‘Quantity One’’ software from
Bio-Rad (version 4.6.8). The intensity of the signal in the control
condition was taken as 100%. Statistically differences between
conditions were analyzed using unpaired Student’s t test
performed using Micrococal Origin version 6.0.
RNA extraction and analysis
Total RNA were extracted with the TRI-Reagent kit (Souffel-
weyersheim, France) according to manufacturer’s instructions.
Total RNA was subjected to real-time quantitative reverse
transcription (RT)-polymerase chain reaction (PCR) analysis as
described in [17]. Primers were designed using Primer Express
software (Applied Biosystems, Courtaboeuf, France) and validated
by testing PCR efficiency using standard curves (85%# efficiency
#115%). Gene expression was quantified using the comparative
CT (threshold cycle) method; TBP was used as reference. The list
of the primers used is provided in supplemental Table S1.
Statistical analysis
Data are shown as means 6 SD. Statistically differences
between groups were analyzed using unpaired Student’s t test and
are indicated on figures as follow: *p#0.05, **p#0.01,
***p#0.001. Statistical analysis were performed using Micrococal
Origin version 6.0 (Northampton, Ma).
Supporting Information
Table S1 List of the primers used. The indicated primers were
used for real-time quantitative reverse transcription (RT)-poly-
merase chain reaction (PCR) analysis.
(TIF)
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